RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19

ID: RRPV-24-02-OralVx • Type: Special Notice

Description

Posted: Oct. 29, 2024, 1:06 p.m. EDT

This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) titled, "NextGen Oral Formulation Vaccines for COVID-19". The purpose of this effort is to advance oral vaccine platforms and technologies into a proof-of-concept Phase 1 clinical trial, improve our understanding of their potential, and to provide better COVID-19 solutions and bolster preparedness and response against future health security threats. The full RPP and information on joining the consortium can be accessed through the RRPV website at www.rrpv.org.

Amended to extend the due date from 18 October 2024 to 1 November 2024.

Amended to extend the due date from 1 November 2024 to 15 November 2024.

Posted: Oct. 1, 2024, 3:02 p.m. EDT

Posted: Sept. 10, 2024, 7:04 a.m. EDT

Overview

Agency

HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) [HHS]

Response Deadline

Nov. 15, 2024, 1:00 p.m. EST (original: Oct. 18, 2024, 1:00 p.m. EDT) Past Due

Posted

Sept. 10, 2024, 7:04 a.m. EDT (updated: Oct. 29, 2024, 1:06 p.m. EDT)

Set Aside

None

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

PSC

AN42 - Health R&D Services; Health Care - Other; Applied Research

Place of Performance

DC United States

Source

SAM

Current SBA Size Standard

1000 Employees

Pricing

Multiple Types Common

On 9/10/24 HHS Office of the Assistant Secretary for Preparedness and Response issued Special Notice RRPV-24-02-OralVx for RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19 due 11/15/24.

Primary Contact

Name

Rebecca Harmon Profile

rebecca.harmon@ati.org

Phone

None

Question & Answer

Incumbent or Similar Awards

Contracts Similar to Special Notice RRPV-24-02-OralVx

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice RRPV-24-02-OralVx

Additional Details

Source Agency Hierarchy

HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > BARDA - ASPR / DAAPPO / BARDA DCMA

FPDS Organization Code

7505-00100

Source Organization Code

100188027

Last Updated

Nov. 30, 2024

Last Updated By

rebecca.foster@hhs.gov

Archive Date